JBIO earnings: a negative outcome, -11.2%

On May 16, 2022, Jade Biosciences, Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.2% in the window around the event. It had already run -22.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.